Rybodyn, Inc.

San Diego, CA

UEI
GHL3YYTLTJK3
CAGE
206L3
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
  • Hispanic American Owned
Entity structure
Corporate Entity (Not Tax Exempt)
NAICS codes registered in SAM.gov
SAM.gov registration date
Physical address
5015 Shoreham Pl ste 150, San Diego, CA 92122, USA
Website
rybodyn.com
Employees
1-10
Estimated annual revenue
$1M-$10M
Industry
  1. Industrials
  2. Commercial & Professional Services
  3. Professional Services
  4. Research & Consulting Services
SIC code
87 Engineering & Management Services
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Recent federal awards

Rybodyn, Inc.'s 2 most recent federal contract and grant awards, newest first. Amounts are dollars obligated.
Award Agency Obligated Awarded
Targeting the dark proteome for making high-resolution immunotherapies for lung cancer Grant · HT9425261E288 Defense Health Agency $1,318,892
A novel spatial biology platform for protein profiling which is cost effective and scalable - abstract spatial biology… Grant · R43GM163236 National Institute of General Medical Sciences $306,700

Quick answers

What is Rybodyn, Inc.'s UEI?

Rybodyn, Inc.'s Unique Entity ID (UEI) in SAM.gov is GHL3YYTLTJK3.

What is Rybodyn, Inc.'s CAGE code?

Rybodyn, Inc.'s CAGE code is 206L3.

What is Rybodyn, Inc.'s primary NAICS code?

Rybodyn, Inc.'s primary NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).

Where is Rybodyn, Inc. located?

Rybodyn, Inc.'s physical address in SAM.gov is 5015 Shoreham Pl ste 150, San Diego, CA 92122, USA.

Is Rybodyn, Inc. registered in SAM.gov?

Yes. Rybodyn, Inc.'s SAM.gov registration is active through May 1, 2027.

What is Rybodyn, Inc.'s most recent federal award?

Rybodyn, Inc.'s most recent federal grant award is Targeting the dark proteome for making high-resolution immunotherapies for lung cancer (HT9425261E288), from Defense Health Agency, on July 1, 2026.

On GovTribe

See Rybodyn, Inc.'s full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login